Endocrinology, Vol 136, 3016-3023, Copyright © 1995 by Endocrine Society

ARTICLES

Further evidence for a novel receptor for amino-terminal parathyroid hormone-related protein on keratinocytes and squamous carcinoma cell lines

JJ Orloff, Y Kats, P Urena, E Schipani, RC Vasavada, WM Philbrick, A Behal, AB Abou-Samra, GV Segre and H Juppner
Division of Endocrinology and Metabolism, West Haven Veterans Affairs Medical Center, Connecticut 06516, USA.

PTH and PTH-related peptides (PTHrPs) interact with a common PTH/PTHrP receptor (type I), which is expressed in many tissues, including bone and kidney. Amino-terminal PTH and PTHrPs also recognize receptors in several nonclassical PTH target tissues, and in some of these, the signaling mechanisms differ qualitatively from those of the classical type I receptor. In normal keratinocytes and squamous carcinoma cell lines, PTH and PTHrP stimulate a rise in intracellular calcium, but not cAMP, suggesting the existence of an alternate, type II PTH/PTHrP receptor. SqCC/Y1 squamous carcinoma cells stably expressing the type I receptor displayed sensitive intracellular cAMP responses to PTHrP and PTH, indicating that these cells express functional GS proteins and that the type I receptor is capable of signaling through adenylyl cyclase in this cell line. Therefore, the endogenous type II receptor in SqCC/Y1 cells differs from the cloned type I receptor. We next examined whether messenger RNA (mRNA) from keratinocytes and squamous cell lines could hybridize to a human type I PTH/PTHrP receptor complementary DNA [1.9 kilobases (kb)]. No type I receptor mRNA (2.3 kb) was detected in polyadenylated RNA from any of the squamous cell lines. However, squamous cell lines did express several mRNA transcripts that hybridized with the type I receptor probe, yet were smaller (1 and 1.5 kb) or larger (3.5-5 kb) than the cloned receptor mRNA. The predominant mRNA in two squamous carcinoma cell lines and normal keratinocytes was a 1-kb transcript. Northern analysis with five different region-specific probes that span the entire coding region of the human type I receptor was used to map homologous regions within each of the transcripts. Several of the transcripts identified in squamous lines are also present in polyadenylated RNA from SaOS-2 human bone cells, but a unique 1-kb transcript hybridizing to probe 2 (nucleotides 490-870) was observed only in squamous cells. The smaller 1- and 1.5-kb transcripts did not hybridize to probes corresponding to the extreme 5'- and 3'-coding regions of the type I receptor complementary DNA. Ribonuclease protection analysis employing riboprobes that correspond to the five region-specific DNA probes revealed strong RNA signals of the expected size in SaOS-2 cells, but no hybridization with squamous cell RNA. Several smaller, but minor, bands that were unique to squamous cells were observed with riboprobe 2 only, suggesting partial homology of this region with the type I receptor.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				D. Wheeler, J. L. Garrido, A. Bisello, Y. K. Kim, P. A. Friedman, and G. Romero Regulation of Parathyroid Hormone Type 1 Receptor Dynamics, Traffic, and Signaling by the Na+/H+ Exchanger Regulatory Factor-1 in Rat Osteosarcoma ROS 17/2.8 Cells Mol. Endocrinol., May 1, 2008; 22(5): 1163 - 1170. [Abstract] [Full Text] [PDF]

				T. M. Murray, L. G. Rao, P. Divieti, and F. R. Bringhurst Parathyroid Hormone Secretion and Action: Evidence for Discrete Receptors for the Carboxyl-Terminal Region and Related Biological Actions of Carboxyl- Terminal Ligands Endocr. Rev., February 1, 2005; 26(1): 78 - 113. [Abstract] [Full Text] [PDF]

				V. A. Tovar Sepulveda, X. Shen, and M. Falzon Intracrine PTHrP Protects against Serum Starvation-Induced Apoptosis and Regulates the Cell Cycle in MCF-7 Breast Cancer Cells Endocrinology, February 1, 2002; 143(2): 596 - 606. [Abstract] [Full Text] [PDF]

				T. MASSFELDER, N. TAESCH, N. ENDLICH, A. EICHINGER, B. ESCANDE, K. ENDLICH, M. BARTHELMEBS, and J.-J. HELWIG Paradoxical actions of exogenous and endogenous parathyroid hormone-related protein on renal vascular smooth muscle cell proliferation: reversion in the SHR model of genetic hypertension FASEB J, March 1, 2001; 15(3): 707 - 718. [Abstract] [Full Text] [PDF]

				J Foley, P Dann, J Hong, J Cosgrove, B Dreyer, D Rimm, M Dunbar, W Philbrick, and J Wysolmerski Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development Development, January 2, 2001; 128(4): 513 - 525. [Abstract] [PDF]

				W. B. Sneddon, F. Liu, F. A. Gesek, and P. A. Friedman Obligate Mitogen-Activated Protein Kinase Activation in Parathyroid Hormone Stimulation of Calcium Transport But Not Calcium Signaling Endocrinology, November 1, 2000; 141(11): 4185 - 4193. [Abstract] [Full Text] [PDF]

				B. Lanske, P. Divieti, C. S. Kovacs, A. Pirro, W. J. Landis, S. M. Krane, F. R. Bringhurst, and H. M. Kronenberg The Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mediates Actions of Both Ligands in Murine Bone Endocrinology, December 1, 1998; 139(12): 5194 - 5204. [Abstract] [Full Text] [PDF]

				T. A. Guise and G. R. Mundy Cancer and Bone Endocr. Rev., February 1, 1998; 19(1): 18 - 54. [Abstract] [Full Text]

				T. Massfelder, P. Dann, T. L. Wu, R. Vasavada, J.-J. Helwig, and A. F. Stewart Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: A critical role for nuclear targeting PNAS, December 9, 1997; 94(25): 13630 - 13635. [Abstract] [Full Text] [PDF]

				J. H. Shin, C. Ji, S. Casinghino, T. L. McCarthy, and M. Centrella Parathyroid Hormone-related Protein Enhances Insulin-like Growth Factor-I Expression by Fetal Rat Dermal Fibroblasts J. Biol. Chem., September 19, 1997; 272(38): 23498 - 23502. [Abstract] [Full Text] [PDF]

				S. Yamamoto, I. Morimoto, N. Yanagihara, K. Zeki, T. Fujihira, F. Izumi, H. Yamashita, and S. Eto Parathyroid Hormone-Related Peptide-(1-34) [PTHrP- (1-34)] Induces Vasopressin Release from the Rat Supraoptic Nucleus in Vitro through a Novel Receptor Distinct from a Type I or Type II PTH/PTHrP Receptor Endocrinology, May 1, 1997; 138(5): 2066 - 2072. [Abstract] [Full Text] [PDF]

				A. Azarani, D. Goltzman, and J. Orlowski Structurally Diverse N-terminal Peptides of Parathyroid Hormone (PTH) and PTH-related Peptide (PTHRP) Inhibit the Na+/H+ Exchanger NHE3 Isoform by Binding to the PTH/PTHRP Receptor Type I and Activating Distinct Signaling Pathways J. Biol. Chem., June 21, 1996; 271(25): 14931 - 14936. [Abstract] [Full Text] [PDF]